Monday, 31 August 2026

Rashtriya Chemicals and Fertilizers Limited Share Price Falls 3.56% (Aug 31, 2026)

Rashtriya Chemicals and Fertilizers Limited
RCF.NS
₹115.55
▼ 3.56%
Rashtriya Chemicals and Fertilizers fell 3.56% to ₹115.55, with no specific news flagged for today's decline. The stock has struggled over both the 1-year and 2-year horizons, down 24.65% and 24.21% respectively, though it has managed modest positive compounding over the longer 5-year and 10-year periods at 9.86% and 9.18% respectively.
CAGR Performance
1 Year2 Years5 Years10 Years
-25.63%-24.70%9.58%9.04%
No comments:

Shivalik Bimetal Controls Limited Share Price Jumps 3.21% (Aug 31, 2026)

Shivalik Bimetal Controls Limited
SBCL.NS
₹1082.95
▲ 3.21%
Shivalik Bimetal Controls climbed 3.21% to ₹1,082.95, with no specific corporate news explaining today's move. The stock's longer-term trajectory has nonetheless been extraordinary, with a 1-year CAGR of 115.18% and a 10-year CAGR of 65.08%, making it one of the standout small-cap compounders in this basket. Coverage is thin, though, with only a single analyst tracking the stock and an average target of ₹995.
CAGR Performance
1 Year2 Years5 Years10 Years
112.49%37.09%56.12%64.69%
Analyst Consensus
Average Target Price: ₹995.00 (range ₹995.00 - ₹995.00) based on 1 analysts
Strong Buy: 0 Buy: 1 Hold: 0 Sell: 0 Strong Sell: 0
No comments:

Persistent Systems Limited Share Price Falls 4.41% (Aug 31, 2026)

Persistent Systems Limited
PERSISTENT.NS
₹5616.00
▼ 4.41%
Persistent Systems fell sharply, down 4.41% to ₹5,616, extending a nearly 11% slide to a near 15-month low as concerns build over its proposed takeover of Germany's Nagarro. Nagarro's own Management and Supervisory Boards have now recommended shareholders accept Persistent's €81-per-share voluntary offer — a hefty 140% premium to Nagarro's June 25 closing price and a 93% premium to its 3-month volume-weighted average — in a deal that values the German IT firm at $1.45 billion including debt. Persistent already holds roughly 21-22% of Nagarro plus commitments for another 15%, and the acceptance window runs until September 17, but analysts have flagged the price tag as excessive, weighing on sentiment. Despite strong long-term compounding — a 5-year CAGR of 27.57% and 10-year CAGR of 33.52% — the stock's 1-year return has slowed to just 3.61%, and the 34-analyst consensus has shifted to Hold with an average target of ₹5,511.71.
CAGR Performance
1 Year2 Years5 Years10 Years
3.60%4.20%27.56%33.52%
Analyst Consensus
Average Target Price: ₹5511.71 (range ₹3310.00 - ₹6931.00) based on 34 analysts
Strong Buy: 7 Buy: 11 Hold: 7 Sell: 6 Strong Sell: 3
No comments:

Aurobindo Pharma Limited Share Price Jumps 2.72% (Aug 31, 2026)

Aurobindo Pharma Limited
AUROPHARMA.NS
₹1690.00
▲ 2.72%
Aurobindo Pharma jumped 2.72% to ₹1,690 after the US FDA wrapped up its inspection of the AuroPeptides Telangana facility with just a single observation, and importantly one tied only to facility and equipment maintenance rather than data integrity or GMP concerns — a relief for a sector where such inspections can move stocks sharply either way. The company said corrective action is already underway, helping offset separate news that subsidiary Lannett Company received four procedural observations from the USFDA the same week. The regulatory clean bill lands alongside a strong Q1FY27 print, with net profit up 25.2% YoY to ₹1,032 crore, revenue up 16.3% to ₹9,150.3 crore, and EBITDA margin improving to 21% from 20%. The stock's 1-year CAGR of 65.08% has been standout even by pharma-sector standards, and with a ₹95,927-crore market cap and 28 analysts averaging a Buy consensus with a target of ₹1,678, sentiment remains firmly positive.
CAGR Performance
1 Year2 Years5 Years10 Years
64.40%3.54%18.26%7.84%
Analyst Consensus
Average Target Price: ₹1678.32 (range ₹1270.00 - ₹1955.00) based on 28 analysts
Strong Buy: 5 Buy: 13 Hold: 5 Sell: 2 Strong Sell: 2
No comments:

Hindustan Zinc Limited Share Price Falls 4.34% (Aug 31, 2026)

Hindustan Zinc Limited
HINDZINC.NS
₹595.00
▼ 4.34%
Hindustan Zinc dropped 4.34% to ₹595, one of the worst hit in today's metal-space rout alongside Vedanta and NALCO, even though its underlying business continues to fire — Q1 revenue came in at ₹13,747 crore with net profit of ₹5,469 crore. The sharper worry for investors appears to be leadership continuity: CEO Arun Misra's tenure ended on July 31 with no successor named, coming just weeks after CFO Sandeep Modi's resignation in May to pursue opportunities elsewhere. That governance uncertainty is playing out even as the company presses ahead with a ₹15,823-crore Phase 1 capacity expansion toward its 2 MTPA target, and HSBC has stuck with a Buy rating and ₹770 target citing strong zinc and silver prices. The stock had rallied nearly 37% over the past year and almost 12% in the month before this fall, so today's decline looks like a pullback after a strong run, with 15 analysts still averaging a Buy consensus and a target of ₹642.93.
CAGR Performance
1 Year2 Years5 Years10 Years
37.31%9.27%13.19%10.17%
Analyst Consensus
Average Target Price: ₹642.93 (range ₹480.00 - ₹770.00) based on 15 analysts
Strong Buy: 0 Buy: 9 Hold: 2 Sell: 3 Strong Sell: 1
No comments:

Shivalik Rasayan Limited Share Price Jumps 5.00% (Aug 31, 2026)

Shivalik Rasayan Limited
SHIVALIK.NS
₹322.19
▲ 5.00%
Shivalik Rasayan hit its 5% upper circuit to close at ₹322.19 after the company received a Certificate of Suitability for Pirfenidone from the European Directorate for Quality of Medicine & Healthcare, its second regulatory win this year following an earlier China API nod for the anti-leukemia drug Bendamustine that had also triggered a similar rally. The move comes off depressed levels — the stock had been down anywhere between 24% and 59% over the past year and was trading near multi-month lows heading into this news. Valuation-wise, the small-cap pharma name trades at a P/E of 33.74x, a steep 47% discount to its peer group's median of 63.66x, though its longer-term CAGRs across 1, 2, 5 and 10 years are all in negative territory, reflecting how sharp the prior drawdown has been.
CAGR Performance
1 Year2 Years5 Years10 Years
-29.24%-23.90%-20.53%-20.53%
No comments:

Vedanta Limited Share Price Falls 3.52% (Aug 31, 2026)

Vedanta Limited
VEDL.NS
₹277.80
▼ 3.52%
Vedanta tumbled 3.52% to ₹277.80 as the stock got caught up in a broader Nifty Metal selloff that also dragged down NALCO and group company Hindustan Zinc. The drop comes despite the company reporting a strong Q1 net profit of ₹5,473 crore and continued balance-sheet repair, with net debt-to-EBITDA improving to 0.95x from 1.22x a year earlier and parent Vedanta Resources' net debt nearly halving to $5.2 billion over four years. Adding to the noise, Vedanta Resources was forced to publicly deny media speculation on August 26 about a potential stake sale in either Vedanta Ltd or Vedanta Aluminium. Longer-term holders have had a rough ride, with the stock down 35.6% over the past year and negative on both the 2- and 5-year CAGR, though its historically generous dividend yield of around 10% has been a partial cushion, and 9 analysts still hold a Buy consensus with an average target of ₹314.89.
CAGR Performance
1 Year2 Years5 Years10 Years
-35.52%-22.90%-1.68%5.05%
Analyst Consensus
Average Target Price: ₹314.89 (range ₹235.00 - ₹350.00) based on 9 analysts
Strong Buy: 2 Buy: 8 Hold: 2 Sell: 1 Strong Sell: 0
No comments:

Pidilite Industries Limited Share Price Jumps 0.52% (Aug 31, 2026)

Pidilite Industries Limited
PIDILITIND.NS
₹1637.90
▲ 0.52%
Pidilite Industries added 0.52% to ₹1,637.90, trading near its 52-week high of ₹1,686 on the back of a robust Q1FY27 showing where consolidated net profit rose 23% YoY to ₹883.51 crore and revenue grew 17% to ₹4,551.55 crore. The core Consumer & Bazaar segment did the heavy lifting, growing 22.5% on strong 12.2% volume growth, while the B2B business also chipped in with a 16% revenue rise. EBITDA margin expanded to 26.23% from 25.07%, underscoring the pricing and cost discipline that has kept the adhesives major a steady compounder — its 10-year CAGR stands at 16.70%. Brokerages are split on how much further the stock can run from here: ICICI Securities has a Buy call with a ₹1,937 target while Emkay stays Neutral at ₹1,655, though the broader analyst base of 21 still averages a Buy consensus with a target of ₹1,786.
CAGR Performance
1 Year2 Years5 Years10 Years
5.18%2.58%7.58%16.74%
Analyst Consensus
Average Target Price: ₹1786.33 (range ₹1400.00 - ₹2065.00) based on 21 analysts
Strong Buy: 9 Buy: 7 Hold: 2 Sell: 2 Strong Sell: 1
No comments:

Sobha Limited Share Price Falls 2.47% (Aug 31, 2026)

Sobha Limited
SOBHA.NS
₹1238.80
▼ 2.47%
Sobha slipped 2.47% to ₹1,238.80, giving back some of the sharp 7% intraday pop it saw after posting record quarterly sales of ₹3,656 crore, up 76% YoY, with net profit more than tripling to ₹50.7 crore. Profit booking set in even as total income climbed 47.6% to ₹1,330 crore, a reminder that at a rich PE of nearly 60x, the market is pricing in a lot of the company's ambitious 30%-plus pre-sales growth target for FY27. The bigger question for investors is margin — Q1FY27 EBITDA margin came in at just 9.7%, and Sobha needs a sharp ramp-up to 17-20% by Q4FY27 to justify that growth narrative. The stock remains well off its 52-week high of ₹1,732.5, and near-term returns have been weak with a 1-year CAGR of -15.12%, but 18 analysts still peg a strong-buy consensus with an average target of ₹1,752, implying meaningful re-rating potential if the margin expansion plays out.
CAGR Performance
1 Year2 Years5 Years10 Years
-13.64%-13.63%15.12%15.96%
Analyst Consensus
Average Target Price: ₹1752.17 (range ₹1480.00 - ₹1930.00) based on 18 analysts
Strong Buy: 2 Buy: 14 Hold: 2 Sell: 0 Strong Sell: 0
No comments:

Brigade Enterprises Limited Share Price Jumps 0.47% (Aug 31, 2026)

Brigade Enterprises Limited
BRIGADE.NS
₹645.25
▲ 0.47%
Brigade Enterprises edged up 0.47% to ₹645.25, holding steady after its Q1FY27 numbers showed net profit surging 37% YoY to ₹217 crore, though a chunk of that came from a ₹36.6 crore exceptional gain rather than core operations. Revenue actually slipped 5% to ₹1,179 crore and residential sales volumes fell 6%, but the real estate business more than made up for it on profitability, with EBITDA margin nearly doubling to 21% from 12% a year ago as realizations jumped 21% to ₹14,256 per sq ft. The company kept its full-year presales guidance intact at ₹9,000 crore and continues to run a conservative balance sheet with net debt of ₹2,218 crore and a debt-equity ratio of just 0.26x. The stock has been a laggard over the past couple of years, down over 15% on a 2-year CAGR basis, but its 10-year track record of 22.43% annualised returns and a strong-buy consensus from 15 analysts with an average target of ₹775 suggest the Street remains constructive on the longer-term story.
CAGR Performance
1 Year2 Years5 Years10 Years
-6.95%-15.34%20.86%22.47%
Analyst Consensus
Average Target Price: ₹775.10 (range ₹560.00 - ₹940.00) based on 15 analysts
Strong Buy: 0 Buy: 14 Hold: 0 Sell: 0 Strong Sell: 1
No comments:

Saturday, 29 August 2026

Dabur India Limited Share Price Falls 1.17% (Aug 27, 2026)

Dabur India Limited
DABUR.NS
₹387.60
▼ 1.17%
Dabur India shares slipped 1.17% to ₹387.60 in a session devoid of any specific company news, extending what has been a rough multi-year stretch for the FMCG major. The stock is down 25.74% over the past year and 22.38% over two years, and even its five-year return remains negative at -8.63%, though it has managed a modest 3.01% CAGR over a full decade. Despite this underperformance, 38 analysts continue to track the stock with an average target of ₹506.26 — well above current trading levels — and the consensus call remains "buy."
CAGR Performance
1 Year2 Years5 Years10 Years
-24.88%-22.60%-8.70%2.97%
Analyst Consensus
Average Target Price: ₹506.26 (range ₹379.00 - ₹625.00) based on 38 analysts
Strong Buy: 9 Buy: 13 Hold: 11 Sell: 3 Strong Sell: 2
No comments:

Marico Limited Share Price Jumps 0.01% (Aug 27, 2026)

Marico Limited
MARICO.NS
₹833.10
▲ 0.01%
Marico shares were flat, up just 0.01% to ₹833.10, with no specific news flow around the stock today. The FMCG major's longer-term trend has been fairly steady, delivering a 16.02% one-year CAGR alongside 11.03%, 9.67% and 11.36% returns over two, five and ten years respectively — a picture of consistent, if unspectacular, compounding. Among the 39 analysts covering the stock, the average target stands at ₹963.82, well above current levels, with the street's consensus call resting at "buy."
CAGR Performance
1 Year2 Years5 Years10 Years
17.13%12.22%9.68%11.36%
Analyst Consensus
Average Target Price: ₹963.82 (range ₹703.00 - ₹1050.00) based on 39 analysts
Strong Buy: 13 Buy: 20 Hold: 5 Sell: 0 Strong Sell: 2
No comments:

Steel Authority of India Limited Share Price Falls 3.46% (Aug 27, 2026)

Steel Authority of India Limited
SAIL.NS
₹188.16
▼ 3.46%
Steel Authority of India was the day's biggest laggard among the pack, sliding 3.46% to ₹188.16, even though no specific news emerged to explain the drop. The fall looks sharper set against its own recent history — the stock has actually rallied an eye-catching 56.63% over the past year, easily the strongest one-year return in this basket, alongside gains of 17.64%, 9.72% and 14.57% over two, five and ten years respectively. With 29 analysts tracking the stock and an average target of ₹178.03 — below the current price — there's currently no clear consensus call on the counter, suggesting today's sharp pullback may simply be some profit-taking after a strong run.
CAGR Performance
1 Year2 Years5 Years10 Years
67.71%22.15%11.07%15.28%
Analyst Consensus
Average Target Price: ₹178.03 (range ₹135.00 - ₹240.00) based on 29 analysts
Strong Buy: 3 Buy: 9 Hold: 4 Sell: 9 Strong Sell: 4
Related News
May 15, 2026 Sail Q4 Net Profit 16.8 Billion Rupees
No comments:

Jindal Steel Limited Share Price Jumps 0.47% (Aug 27, 2026)

Jindal Steel Limited
JINDALSTEL.NS
₹1180.90
▲ 0.47%
Jindal Steel bucked the weakness in the broader metals space, edging up 0.47% to ₹1180.90, even as sector peer SAIL tumbled over 3% in the same session. There was no specific news driving today's move, but the stock's longer-term performance has been consistently strong, clocking a 20.75% one-year CAGR, 10.39% over two years, and an impressive 26% and 30.05% over five and ten years respectively. That momentum appears to be reflected in analyst sentiment too, with 32 analysts maintaining an average "buy" consensus and a price target of ₹1219.59, marginally above current trading levels.
CAGR Performance
1 Year2 Years5 Years10 Years
22.23%10.32%25.96%30.03%
Analyst Consensus
Average Target Price: ₹1221.78 (range ₹590.00 - ₹1410.00) based on 32 analysts
Strong Buy: 6 Buy: 16 Hold: 4 Sell: 2 Strong Sell: 2
No comments:

UCO Bank Share Price Falls 1.53% (Aug 27, 2026)

UCO Bank
UCOBANK.NS
₹25.79
▼ 1.53%
UCO Bank shares fell 1.53% to ₹25.79 on Wednesday, with no specific company news behind the move. The stock's track record has been volatile — down 9.26% over one year and a sharp 29.23% over two years — though it did manage a 15.21% CAGR over five years, a stretch that outpaces its own ten-year return, which is actually negative at -4.38%, highlighting just how uneven the ride has been for long-term shareholders.
CAGR Performance
1 Year2 Years5 Years10 Years
-9.58%-29.46%14.93%-4.49%
No comments:

Indian Overseas Bank Share Price Falls 0.67% (Aug 27, 2026)

Indian Overseas Bank
IOB.NS
₹32.88
▼ 0.67%
Indian Overseas Bank eased 0.67% to ₹32.88 in a session that lacked any specific triggers for the stock. Zooming out, the counter's longer-term chart tells a rougher story — down 13.85% over the past year and a steep 26.80% over two years — though it has managed a 10.95% five-year CAGR, a reminder that public sector bank stocks have had sharp cyclical swings. The ten-year picture is far more muted at just 2.22% annualised, underscoring how much of the recent volatility has weighed on long-term compounding.
CAGR Performance
1 Year2 Years5 Years10 Years
-14.06%-26.50%10.90%2.20%
No comments:

Dr. Reddy's Laboratories Limited Share Price Falls 1.00% (Aug 27, 2026)

Dr. Reddy's Laboratories Limited
DRREDDY.NS
₹1170.20
▼ 1.00%
Dr. Reddy's Laboratories slipped 1% to ₹1170.20 after the US FDA flagged four observations following a GMP inspection at its FTO-3 formulations facility in Hyderabad conducted between August 6 and 14, 2026 — a smaller haul than the seven observations from a similar inspection back in June. The stock, now down nearly 17% from its 52-week high of ₹1414.9, has been a serial underperformer, shedding 7.34% over the past year and 8.33% over two years, even as its five- and ten-year returns of 4.92% and 6.72% suggest longer-term holders have fared somewhat better. Regulatory scrutiny has been a recurring theme for the company, with earlier disclosures made to exchanges in October 2023 and September 2025 as well. Of the 39 analysts covering the stock, the average price target sits at ₹1265.77, though there's currently no clear consensus call on the name.
CAGR Performance
1 Year2 Years5 Years10 Years
-6.49%-8.27%5.06%6.79%
Analyst Consensus
Average Target Price: ₹1265.77 (range ₹1039.00 - ₹1740.00) based on 39 analysts
Strong Buy: 4 Buy: 11 Hold: 11 Sell: 5 Strong Sell: 8
No comments:

Zydus Lifesciences Limited Share Price Jumps 2.11% (Aug 27, 2026)

Zydus Lifesciences Limited
ZYDUSLIFE.NS
₹1174.20
▲ 2.11%
Zydus Lifesciences climbed 2.11% to ₹1174.20, holding close to its 52-week high of ₹1181.50 touched back on July 8, even as its June-quarter numbers showed a mixed picture — consolidated revenue grew a healthy 21.95% YoY to Rs 8,017 crore, but net profit slumped 35.93% to Rs 939.8 crore as EBITDA margins contracted sharply by 770 basis points to 24.1%. Despite the margin pressure, brokerages have stayed constructive on the stock, with Jefferies raising its target to Rs 1,200 from Rs 1,100 while maintaining a "Buy" call, and Prabhudas Lilladher sticking with an "Accumulate" rating and the same Rs 1,200 target. The stock has delivered a strong 18.79% return over the past year, though its two-year CAGR of just 2.65% points to a choppier medium-term journey. With 30 analysts tracking the counter and an average target of ₹1195.78 — barely above current levels — the street's consensus view stands at "hold."
CAGR Performance
1 Year2 Years5 Years10 Years
21.52%2.21%16.63%12.05%
Analyst Consensus
Average Target Price: ₹1195.78 (range ₹800.00 - ₹1457.48) based on 30 analysts
Strong Buy: 7 Buy: 8 Hold: 8 Sell: 3 Strong Sell: 4
No comments:

Wednesday, 26 August 2026

IndusInd Bank Limited Share Price Falls 1.56% (Aug 26, 2026)

IndusInd Bank Limited
INDUSINDBK.NS
₹999.20
▼ 1.56%
IndusInd Bank was the outlier among today's banking movers, slipping 1.56% to ₹999.20 with no specific news flagged for the decline. The stock has still managed a 32.18% gain over the past year, but the picture turns choppier further back, with a 2-year CAGR of -15.02% and near-flat five and ten-year returns, reflecting a turbulent stretch for the private lender. Coverage from 37 analysts puts the average target price at ₹992.86 — just shy of the current market price — with the consensus rating pegged at "hold."
CAGR Performance
1 Year2 Years5 Years10 Years
32.73%-14.84%0.05%-1.46%
Analyst Consensus
Average Target Price: ₹992.86 (range ₹625.00 - ₹1250.00) based on 37 analysts
Strong Buy: 3 Buy: 5 Hold: 14 Sell: 7 Strong Sell: 8
No comments:

Kotak Mahindra Bank Limited Share Price Jumps 2.66% (Aug 26, 2026)

Kotak Mahindra Bank Limited
KOTAKBANK.NS
₹412.30
▲ 2.66%
Kotak Mahindra Bank rose 2.66% to ₹412.30, making it one of the day's stronger private bank performers, even though no specific news was tied to the move. The stock's longer-term returns look comparatively subdued next to some PSU lenders — up just under 5% over one year and under 7% over two years — though its 10-year CAGR of 10.19% points to steadier, if less spectacular, compounding over time. A large coverage base of 37 analysts carries an average target price of ₹463.78 on the stock, well above current levels, with a "buy" consensus rating attached.
CAGR Performance
1 Year2 Years5 Years10 Years
5.99%7.22%4.18%10.31%
Analyst Consensus
Average Target Price: ₹463.78 (range ₹380.00 - ₹518.00) based on 37 analysts
Strong Buy: 9 Buy: 21 Hold: 6 Sell: 1 Strong Sell: 0
No comments:
Subscribe to: Posts (Atom)

Shivalik Rasayan Limited Share Price Falls 2.67% (Sep 11, 2026)

Shivalik Rasayan Limited SHIVALIK.NS ₹357.00 ▼ 2.67% Shivalik Rasayan slipped 2.67%...